Dose finding with escalation with overdose control (EWOC) in cancer clinical trials (Q903293): Difference between revisions

From MaRDI portal
Importer (talk | contribs)
Changed an Item
ReferenceBot (talk | contribs)
Changed an Item
Property / cites work
 
Property / cites work: Optimal Bayesian-feasible dose escalation for cancer phase I trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Coherence principles in dose-finding studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities / rank
 
Normal rank
Property / cites work
 
Property / cites work: Unifying CRM and EWOC designs for phase I cancer clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q5654899 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: TWO-SAMPLE CONTINUAL REASSESSMENT METHOD / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose finding in drug development. / rank
 
Normal rank

Revision as of 06:35, 11 July 2024

scientific article
Language Label Description Also known as
English
Dose finding with escalation with overdose control (EWOC) in cancer clinical trials
scientific article

    Statements

    Dose finding with escalation with overdose control (EWOC) in cancer clinical trials (English)
    0 references
    0 references
    0 references
    5 January 2016
    0 references
    cancer phase I trials
    0 references
    dose-limiting toxicity
    0 references
    escalation with overdose control
    0 references
    tolerated dose
    0 references
    optimal Bayesian feasible
    0 references
    0 references
    0 references

    Identifiers

    0 references
    0 references
    0 references
    0 references
    0 references
    0 references